(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...

Only a few months after Medtronic completed its acquisition of cardiac device maker Affera, the nearly billion-dollar buyout is already paying off. A dual-use catheter originally developed by Affera ...

There is an indisputable trend toward minimally invasive, outpatient procedures in healthcare. Outpatient procedures help to alleviate burdens on the healthcare system, save patients time, money, and ...

Abbott scored two device approvals for its cardiac ablation catheters for treating abnormal heart rhythms—one on each side of the pond. In Europe, the company received a CE Mark for its Tactiflex ...

STATEN ISLAND, N.Y. — Physicians at Staten Island University Hospital (SIUH) are successfully performing a groundbreaking cardiac ablation procedure guided by a first-of-its-kind, approved holographic ...

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announces the launch of CARTO™ 3 System Version 8, the latest version of the company's ...

Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc.

Boston Scientific (NYSE: BSX) announced recently that it received CE mark for its Farapoint pulsed field ablation (PFA) ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...